PP Barn

RTI Biologics is one of the leaders in tissue-based innovations that are used to repair and promote the natural healing of human bone and other tissues. The company processes human musculoskeletal and other tissues, including bone, cartilage, tendon, ligament, pericardial and cardiovascular tissue to produce allograft implants. Surgeons then implant these allografts to repair a wide variety of bone and other tissue defects, including spinal vertebrae repair, musculoskeletal reconstruction, fracture repair, periodontal repair, urinary incontinence and heart valve disorders. RTI Biologics patented BioCleanse tissue sterilization process eliminates bacteria, fungi, spores and viruses from the tissue. The sterilization process also removes all blood, fats, lipids and cellular debris from the tissue. The company continues researching new ways to use allografts in the natural healing of patients. RTI Biologics is headquartered in Alachua, Fla., with a cardiovascular branch in Birmingham, Ala.

GeoLine Surveying Inc., based in Alachua, FL, specializes in a wide range of surveying services, including ALTA ACSM land title surveys, cellular tower surveys, and FAA communication tower certifications. With a nationwide network of professionally licensed land surveyors, the company is equipped to handle projects across all 50 states and Puerto Rico, ensuring high-quality results for commercial, retail, and industrial real estate clients. Committed to excellence, GeoLine Surveying offers clients a single point of contact throughout their project, backed by decades of experience and a thorough review process for all surveys before final submission. Their extensive network of trusted consultants and dedication to meeting project deadlines positions them as a reliable partner in the surveying industry. Generated from the website

Florida Biologix, headquartered in Alachua, FL, is a preclinical and early clinical biologics contract development, manufacturing, and testing organization. Established in 2006 as part of the University of Florida's Center of Excellence for Regenerative Health Biotechnology, the company focuses on a wide range of value-optimizing services, including cell line engineering, cGMP cell banking, and regulatory support. In 2015, Florida Biologix transitioned to a private entity with an investment from Ampersand Capital Partners and later merged with a Massachusetts-based biotechnology company to form Brammer Bio. This merger allowed the company to expand its offerings in viral vector process and analytical development, ultimately becoming part of Thermo Fisher Scientific's Viral Vector Services business in 2019. Generated from the website